Page last updated: 2024-08-23

atomoxetine hydrochloride and Weight Loss

atomoxetine hydrochloride has been researched along with Weight Loss in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albayrak, O; Hebebrand, J; Hinney, A; Pauli-Pott, U; Pott, W	1
Bardenstein, LM; Jarkova, NB; Kozlova, IA; Martenyi, F; Maslova, OI; Neznanov, NG; Petrukhin, AS; Soldatenkova, VO; Sukchotina, NK; Yarosh, AA; Zavadenko, NN; Zykov, VP	1
Allison, DB; Foust, MS; Gadde, KM; Wagner, HR; Yonish, GM	1

Trials

2 trial(s) available for atomoxetine hydrochloride and Weight Loss

Article	Year
Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia. European child & adolescent psychiatry, 2010, Volume: 19, Issue:1 Topics: Abdominal Pain; Adolescent; Adrenergic Uptake Inhibitors; Analysis of Variance; Anorexia; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Method; Female; Humans; Nausea; Parents; Propylamines; Psychiatric Status Rating Scales; Russia; Sleep; Treatment Outcome; Weight Loss	2010
Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial. International journal of obesity (2005), 2006, Volume: 30, Issue:7 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Anti-Obesity Agents; Atomoxetine Hydrochloride; Body Mass Index; Double-Blind Method; Female; Humans; Middle Aged; Obesity; Propylamines; Treatment Outcome; Weight Loss	2006

Article

Year

Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia.

European child & adolescent psychiatry, 2010, Volume: 19, Issue:1

Topics: Abdominal Pain; Adolescent; Adrenergic Uptake Inhibitors; Analysis of Variance; Anorexia; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Method; Female; Humans; Nausea; Parents; Propylamines; Psychiatric Status Rating Scales; Russia; Sleep; Treatment Outcome; Weight Loss

2010

Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.

International journal of obesity (2005), 2006, Volume: 30, Issue:7

Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Anti-Obesity Agents; Atomoxetine Hydrochloride; Body Mass Index; Double-Blind Method; Female; Humans; Middle Aged; Obesity; Propylamines; Treatment Outcome; Weight Loss

2006

Other Studies

1 other study(ies) available for atomoxetine hydrochloride and Weight Loss

Article	Year
Successful treatment with atomoxetine of an adolescent boy with attention deficit/hyperactivity disorder, extreme obesity, and reduced melanocortin 4 receptor function. Obesity facts, 2013, Volume: 6, Issue:1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; DNA Mutational Analysis; Genetic Predisposition to Disease; Humans; Male; Mutation; Obesity; Phenotype; Propylamines; Receptor, Melanocortin, Type 4; Risk Reduction Behavior; Treatment Outcome; Weight Loss	2013

Article

Year

Successful treatment with atomoxetine of an adolescent boy with attention deficit/hyperactivity disorder, extreme obesity, and reduced melanocortin 4 receptor function.

Obesity facts, 2013, Volume: 6, Issue:1

Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; DNA Mutational Analysis; Genetic Predisposition to Disease; Humans; Male; Mutation; Obesity; Phenotype; Propylamines; Receptor, Melanocortin, Type 4; Risk Reduction Behavior; Treatment Outcome; Weight Loss

2013